LBX Pharmacy Chain

Equities

603883

CNE1000023Q8

Drug Retailers

End-of-day quote Shanghai S.E. 06:00:00 2024-06-19 pm EDT 5-day change 1st Jan Change
28.7 CNY -3.24% Intraday chart for LBX Pharmacy Chain -7.84% -3.98%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Nanhua Futures CFO Steps Down MT
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Nomura Adjusts LBX Pharmacy Chain’s Price Target to 45.79 Yuan From 43.96 Yuan, Keeps at Buy MT
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Nomura Adjusts LBX Pharmacy Chain's Price Target to 43.96 Yuan From 44.28 Yuan, Keeps at Buy MT
LBX Pharmacy Chain Joint Stock Company agreed to acquire 35% stake in Yangzhou Baixinyuan Pharmaceutical Chain Co., Ltd. from Chen Jinxi for CNY210 million. CI
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Nomura Adjusts LBX Pharmacy's Price Target to 44.28 Yuan From 42.20 Yuan, Keeps at Buy MT
Bank of Qinghai Gets New Majority Shareholder MT
Nomura Starts LBX Pharmacy Chain at Buy With 42.2 Yuan Price Target MT
China recovery looms large at Sohn 2023 hedge fund conference RE
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Hello Group Chief Executive Li Wang Resigns MT
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
UBS Adjusts LBX Pharmacy Chain's Price Target to 40 Yuan From 36.5 Yuan, Keeps at Buy MT
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Chairman to Boost Shanghai Bio-heart Stake MT
Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online MT
UBS Adjusts LBX Pharmacy Chain's Price Target to 47.50 Yuan From 81.50 Yuan, Keeps at Buy MT
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the Full Year Ended December 31, 2021 CI
LBX Pharmacy Chain Joint Stock Company Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
LBX Pharmacy Chain Joint Stock Company singed an Asset Purchase Agreement to acquire a 71.9% stake in Hunan Huairen Great Health Industry Development Co., Ltd. from group of sellers for CNY 1.6 billion. CI
LBX Pharmacy Chain Joint Stock Company cancelled the acquisition of 51% stake in Hebei Hua Tuo Pharmacy Medicine Chain Co., Ltd. from Zhang Weijun, Tian Jinping, Ma Zhirong and Guo Zhihong. CI
Chart LBX Pharmacy Chain
More charts
LBX Pharmacy Chain Joint Stock Company is a China-based company engaged in pharmaceutical retail chain operation. The Company involves in retailing drugs and other related products, including Chinese and Western medicines, prepared slices of Chinese crude drugs, health Chinese medicines, health equipment, healthy food, personal care products and life care products, among others. The Company also involves in wholesale and manufacture of drugs.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
28.7 CNY
Average target price
43.04 CNY
Spread / Average Target
+49.97%
Consensus